ARQT
Arcutis Biotherapeutics, Inc.
NMS
$24.38
-0.21
(-0.85%)
Extended · +1.97σ
Grade B
Valuation
Market cap
$3.0B
P/E (ttm)
—
Forward P/E
21.1
Beta (5y)
1.52
Shares out
125.1M
Div yield
—
Profitability & returns
ROE
-1.4%
Net margin
-0.6%
FCF margin
0.9%
Debt / equity
0.60
Trading information
Last price
$24.38
Day range
$24.38 – $24.38
52-wk range
$19.30 – $30.75
Avg volume
1.6M
RSI (2)
80.6
TAO zone
Extended
Company
Sector
Healthcare
Industry
Biotechnology
Exchange
NMS
Next earnings
2026-08-05
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selec…